elecell’s Research on Reactive Oxygen Species Removal Technology for Wound Healing Published in a Leading International Biomaterials Journal (BioactiveMaterials, IF=18.0)

elecell’s Research on Reactive Oxygen Species Removal Technology for Wound Healing Published in a Leading International Biomaterials Journal

The Korean biotech company eleccell (CEO Hyung-seop Han) announced on February 14, 2025, that it has published a scientific review paper on reactive oxygen species (ROS) removal technology, a key factor in wound healing, in Bioactive Materials, one of the top international journals in the biomaterials field.

The paper discusses various control technologies and scientific principles related to reactive oxygen species, which are known to be excessively generated at wound sites, causing tissue damage and delaying the healing process.

Paper link: https://doi.org/10.1016/j.bioactmat.2025.01.023